Regulation of β-amyloid stimulated proinflammatory responses by peroxisome proliferator-activated receptor α

Neurochemistry International

Volumn 39, Issue 5-6, 2001, Pages 449-457

  Combs, Colin K ^a   Bates, Patricia ^a   Karlo, J Colleen ^a   Landreth, Gary E ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CYCLOOXYGENASE 2; INTERLEUKIN 6; ISOENZYME; LIPOPOLYSACCHARIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PIRINIXIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INFLAMMATION; MACROPHAGE; MONOCYTE; MOUSE; NEUROTOXICITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; STIMULUS RESPONSE;

AMYLOID; AMYLOID BETA-PROTEIN; CELL DIFFERENTIATION; CELL LINE; CYCLOOXYGENASE 2; HUMANS; INFLAMMATION; INTERLEUKIN-6; ISOENZYMES; MACROPHAGES; MEMBRANE PROTEINS; MICROGLIA; MONOCYTES; NEUROTOXINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN-TYROSINE KINASES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LIPOPROTEIN; RECEPTORS, SCAVENGER; SCAVENGER RECEPTORS, CLASS B; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034813586     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(01)00052-3     Document Type: Article

References (49)

1. Inflammation and Alzheimer's disease: Mechanisms and therapeutic strategies
2. Inflammation and Alzheimer's disease
3. Cytotoxicity of microglia
4. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
5. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
6. The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease
7. Inflammatory mechanisms in Alzheimer's disease: Inhibition of β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonists
8. Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of β-amyloid and prion proteins
9. Peroxisome proliferator-activated receptor α negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1
10. The PPARα-leukotriene B4 pathway to inflammation control
11. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils
12. Reactive glia as rivals in regulating neuronal survival
13. Microglia and the immune pathology of Alzheimer disease
14. Characterization of ameboid microglia isolated from developing mammalian brain
15. Reactive mononuclear phagocytes release neurotoxins after ischemic and traumatic injury to the central nervous system
16. Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain
17. Specific domains of β-amyloid from Alzheimer plaque elicit neuron killing in human microglia
18. Degradation of the peroxisome proliferator-activated receptor-γ is linked to ligand-dependent activation
19. Peroxisome proliferator-activated receptor-γ agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase
20. Peroxisome proliferator-activated receptor-γ ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo
21. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
22. Microglia and Alzheimer's Disease
23. Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-γ in Alzheimer's disease brains
24. Interaction of Alzheimer β-amyloid peptide with the human monocytic cell line THP-1 results in a protein kinase C-dependent secretion of tumor necrosis factor-α
25. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs
26. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease
27. Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging
28. Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia
29. Inflammation of the brain in Alzheimer's disease: Implications for therapy
30. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies
31. Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with β-amyloid [25-35]
32. Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a scavenger receptor
33. Peroxisome proliferator-activated receptor α activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging
34. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease
35. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
36. Results of a double-blind, randomized, placebo-controlled study of celecoxib in the treatment of Alzheimer's Disease
37. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
38. Images in neuroscience. Alzheimer's disease: From genes to pathogenesis
39. Activation of PPARα or g reduces secretion of matrix metalloproteinase 9 but not IL-8 from human monocytic THP-1 cells
40. Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
41. Risk of Alzheimer's disease and duration of NSAID use
42. The brain's immune system
43. PPARα activation by Wy 14643 induces transactivation of the rat UCP-1 promoter without increasing UCP-1 mRNA levels and attenuates PPARγ-mediated increases in UCP-1 mRNA levels induced by rosiglitazone in fetal rat brown adipocytes
44. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester
45. Anti-inflammatory drugs and their mechanism of action
46. A new mechanism of neurodegeneration: A proinflammatory cytokine inhibits receptor signaling by a survival peptide
47. The PPARs: From orphan receptors to drug discovery
48. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
49. Lipopolysaccharide induction of the tumor necrosis factor-α promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors